Manufacture, Distribution, and Promotion of Adulterated, Misbranded, orUnapproved New Drugs for Human Use by State-Licensed Pharmacies. FDA Compliance Policy Guides. Chapter 32-Drugs General

摘要

Pharmacies engaged in promotion and other activities analogous to manufacturingand distributing drugs for human use are subject to the same provisions of the Act as manufacturers. The guide sets forth regulatory action guidance in such cases.